Trial
NCT05340257
A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Infections, Bacterial
Intervention
Augmentin ES
Why stopped
Business Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-28